FCT. - SFRH/BD/38074/2007
Long-chain fatty acid-oxidation defects are associated with a series of clinical and biochemical abnormalities, including accumulation of long-chain acyl-CoA esters which have been shown to inhibit several enzymes and transport systems that may disturb en